We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+24.55%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$8.79B
AUM Growth
+$1.45B
Cap. Flow
-$72.5M
Cap. Flow %
-0.82%
Top 10 Hldgs %
20.48%
Holding
2,420
New
180
Increased
1,163
Reduced
213
Closed
125

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$8.64M
2
WORK
Slack Technologies, Inc.
WORK
+$7.6M
3
ABBV icon
AbbVie
ABBV
+$7.02M
4
TMUS icon
T-Mobile US
TMUS
+$6.46M
5
OTIS icon
Otis Worldwide
OTIS
+$5.52M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$143M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$19M
3
AGN
Allergan plc
AGN
+$15M
4
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$13.8M
5
MUB icon
iShares National Muni Bond ETF
MUB
+$10.6M

Sector Composition

Rank Sector Weight
1 Technology 21.58%
2 Healthcare 14.02%
3 Financials 12.88%
4 Consumer Discretionary 10.4%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AKBA icon
1126
Akebia Therapeutics
AKBA
$241M
$790K 0.01%
58,177
+5,951
+11% +$61.6K
STLA icon
1127
Stellantis
STLA
$20.2B
$787K 0.01%
78,476
– –
PRNB
1128
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
$784K 0.01%
13,120
+4,928
+60% +$304K
RHP icon
1129
Ryman Hospitality Properties
RHP
$7.87B
$784K 0.01%
22,657
+1,467
+7% +$48.7K
QGEN icon
1130
Qiagen
QGEN
$8.93B
$783K 0.01%
17,159
+2,857
+20% +$128K
AIN icon
1131
Albany International
AIN
$1.82B
$783K 0.01%
13,340
– –
DEA
1132
Easterly Government Properties
DEA
$1.18B
$783K 0.01%
13,541
+854
+7% +$54.2K
BMCH
1133
DELISTED
BMC Stock Holdings, Inc
BMCH
$783K 0.01%
31,130
+3,664
+13% +$81.1K
TPTX
1134
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$782K 0.01%
12,114
– –
LOGI icon
1135
Logitech
LOGI
$15B
$782K 0.01%
+11,995
New +$639K
ATRC icon
1136
AtriCure
ATRC
$2.21B
$782K 0.01%
17,394
+1,124
+7% +$48.9K
ALLK
1137
DELISTED
Allakos
ALLK
$779K 0.01%
10,839
+2,613
+32% +$175K
CVET
1138
DELISTED
Covetrus, Inc. Common Stock
CVET
$777K 0.01%
+43,405
New +$571K
PRO
1139
DELISTED
PROS Holdings
PRO
$772K 0.01%
17,377
+2,715
+19% +$95.8K
FCPT icon
1140
Four Corners Property Trust
FCPT
$2.76B
$772K 0.01%
31,625
+1,807
+6% +$38.8K
APG icon
1141
APi Group
APG
$18.8B
$771K 0.01%
+95,196
New +$720K
APAM icon
1142
Artisan Partners
APAM
$3.03B
$771K 0.01%
23,716
+2,644
+13% +$73.3K
KRTX
1143
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$771K 0.01%
6,914
+2,279
+49% +$198K
PRGS icon
1144
Progress Software
PRGS
$1.83B
$769K 0.01%
19,846
– –
SKYW icon
1145
Skywest
SKYW
$4.21B
$768K 0.01%
23,550
+2,677
+13% +$79.2K
AVAV icon
1146
AeroVironment
AVAV
$9.59B
$767K 0.01%
9,628
+661
+7% +$42.6K
WCC
1147
WESCO International
WCC
$17.5B
$765K 0.01%
+21,795
New +$651K
GTLS
1148
DELISTED
Chart Industries
GTLS
$765K 0.01%
15,776
– –
MGLN
1149
DELISTED
Magellan Health Services, Inc.
MGLN
$763K 0.01%
10,450
+717
+7% +$45.9K
RMBS icon
1150
Rambus
RMBS
$10.8B
$759K 0.01%
49,965
– –
44 45
46
47 48

Similar funds

Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
NAM
Nissay Asset Management Tokyo, Japan $18.9B AUM 27.21% 1-Year Est. Return
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return

MetLife Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, MetLife Investment Management held 2,420 positions worth $8.79B, up 20% from $7.34B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

MetLife Investment Management's Q2 2020 filing shows 180 new, 1,163 increased, 213 reduced and 125 closed positions. Its largest new stake was DexCom: 96,564 shares worth $9.79M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $143M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q2 2020 buy was DexCom: 96,564 shares worth $9.79M.
  • MetLife Investment Management added most to AbbVie in Q2 2020, an estimated $7.02M increase.
  • MetLife Investment Management's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $143M.
  • MetLife Investment Management fully exited Allergan plc in Q2 2020, selling an estimated $15M.
  • MetLife Investment Management's ten largest holdings make up 20% of its $8.79B portfolio in Q2 2020.
  • MetLife Investment Management opened 180 new positions and closed 125 in Q2 2020.
  • MetLife Investment Management's portfolio value rose 20% quarter-over-quarter to $8.79B.

Based on MetLife Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.